172
Views
47
CrossRef citations to date
0
Altmetric
Review

Use of attenuated bacteria as delivery vectors for DNA vaccines

, &
Pages 97-110 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Luis G Bermúdez-Humarán & Philippe Langella. (2010) Perspectives for the development of human papillomavirus vaccines and immunotherapy. Expert Review of Vaccines 9:1, pages 35-44.
Read now
Amit K Goyal, Kapil Khatri, Neeraj Mishra & Suresh P Vyas. (2008) New patents on mucosal delivery of vaccines. Expert Opinion on Therapeutic Patents 18:11, pages 1271-1288.
Read now

Articles from other publishers (44)

Eric Tartour & Ludger Johannes. (2022) STxB as an Antigen Delivery Tool for Mucosal Vaccination. Toxins 14:3, pages 202.
Crossref
Nabendu Debnath, Mony Thakur, Khushboo, Neelam P. Negi, Vibhav Gautam, Ashok Yadav & Deepak Kumar. (2021) Insight of oral vaccines as an alternative approach to health and disease management: An innovative intuition and challenges. Biotechnology and Bioengineering 119:2, pages 327-346.
Crossref
Jie Li, Lei Tang, Pengmei Wang, Guiyang Li, Huaiyuan Jin & Zhaolan Mo. (2021) Identification and application of T3SS translocation signal in Edwardsiella piscicida attenuated carrier as a bivalent vaccine . Journal of Fish Diseases 44:5, pages 513-520.
Crossref
Yu Chen, Xiaoqing Liu, Yanxia Guo, Jianchuan Wang, Dingxiao Zhang, Yang Mei, Junfeng Shi, Wenzhi Tan & Jin Hai Zheng. (2021) Genetically engineered oncolytic bacteria as drug delivery systems for targeted cancer theranostics. Acta Biomaterialia 124, pages 72-87.
Crossref
Sahil Verma & Uttam C. Banerjee. 2021. Probiotic Research in Therapeutics. Probiotic Research in Therapeutics 315 333 .
Nina D. Coelho-Rocha, Fernanda A. L. Barroso, Laísa M. Tavares, Ester S. S. dos Santos, Vasco Azevedo, Mariana M. Drumond & Pamela Mancha-Agresti. 2021. DNA Vaccines. DNA Vaccines 285 304 .
Mark C. Fernandez & Lorenzo Giacani. 2020. Sexually Transmitted Infections. Sexually Transmitted Infections 391 411 .
Nitin Machindra Kamble, Amal Senevirathne, Hong Bum Koh, Jae Il Lee & John Hwa Lee. (2019) Self-destructing Salmonella via temperature induced gene E of phage PhiX174 improves influenza HA DNA vaccine immune protection against H1N1 infection in mice model. Journal of Immunological Methods 472, pages 7-15.
Crossref
Byoung-Jun Kim, Bo-Ram Kim, Yoon-Hoh Kook & Bum-Joon Kim. (2018) Development of a Live Recombinant BCG Expressing Human Immunodeficiency Virus Type 1 (HIV-1) Gag Using a pMyong2 Vector System: Potential Use As a Novel HIV-1 Vaccine. Frontiers in Immunology 9.
Crossref
Gustavo Domínguez-Bernal, Abel Martínez-Rodrigo, Alicia Mas, M. Mar Blanco, José A. Orden, Ricardo De La Fuente & Javier Carrión. (2017) Alternative strategy for visceral leishmaniosis control: HisAK70-Salmonella Choleraesuis-pulsed dendritic cells. Comparative Immunology, Microbiology and Infectious Diseases 54, pages 13-19.
Crossref
Lukas Schwarz, Mariana Medina-Sánchez & Oliver G. Schmidt. (2017) Hybrid BioMicromotors. Applied Physics Reviews 4:3.
Crossref
Bhrugu Yagnik, Drashya Sharma, Harish Padh & Priti Desai. (2017) Dual recombinant Lactococcus lactis for enhanced delivery of DNA vaccine reporter plasmid pPERDBY . Microbiology and Immunology 61:3-4, pages 123-129.
Crossref
Byoung-Jun Kim, Jeong-Ryeol Gong, Ga-Na Kim, Bo-Ram Kim, So-Young Lee, Yoon-Hoh Kook & Bum-Joon Kim. (2017) Recombinant Mycobacterium smegmatis with a pMyong2 vector expressing Human Immunodeficiency Virus Type I Gag can induce enhanced virus-specific immune responses. Scientific Reports 7:1.
Crossref
Miao Wang, Zeqian Gao, Yongguang Zhang & Li Pan. (2016) Lactic acid bacteria as mucosal delivery vehicles: a realistic therapeutic option. Applied Microbiology and Biotechnology 100:13, pages 5691-5701.
Crossref
Fred Zepp. 2016. Vaccine Design. Vaccine Design 57 84 .
Zhu-Ling Guo, Bin Yu, Bo-Tao Ning, Shing Chan, Qiu-Bin Lin, James Chun-Bong Li, Jian-Dong Huang & Godfrey Chi-Fung Chan. (2015) Genetically modified "obligate" anaerobic Salmonella typhimurium as a therapeutic strategy for neuroblastoma. Journal of Hematology & Oncology 8:1.
Crossref
Tai-Chun Chung, Charles H. Jones, Akhila Gollakota, Mahmoud Kamal Ahmadi, Snehal Rane, Guojian Zhang & Blaine A. Pfeifer. (2015) Improved Escherichia coli Bactofection and Cytotoxicity by Heterologous Expression of Bacteriophage ΦX174 Lysis Gene E . Molecular Pharmaceutics 12:5, pages 1691-1700.
Crossref
Agnieszka Wyszyńska, Patrycja Kobierecka, Jacek Bardowski & Elżbieta Katarzyna Jagusztyn-Krynicka. (2015) Lactic acid bacteria—20 years exploring their potential as live vectors for mucosal vaccination. Applied Microbiology and Biotechnology 99:7, pages 2967-2977.
Crossref
Hyungki Lee, Byoung-Jun Kim, Bo-Ram Kim, Yoon-Hoh Kook & Bum-Joon Kim. (2015) The Development of a Novel Mycobacterium-Escherichia coli Shuttle Vector System Using pMyong2, a Linear Plasmid from Mycobacterium yongonense DSM 45126T. PLOS ONE 10:3, pages e0122897.
Crossref
Joana Torres, Silvio Danese & Jean-Frédéric Colombel. (2013) New therapeutic avenues in ulcerative colitis: thinking out of the box. Gut 62:11, pages 1642-1652.
Crossref
Limpon Bora. (2013) Computational drug target identification in Streptococcus pneumoniae using available microarray data. Journal of Pharmacy Research 6:4, pages 404-408.
Crossref
Avinash K. Shetty & Yvonne A. Maldonado. 2013. Vaccinophobia and Vaccine Controversies of the 21st Century. Vaccinophobia and Vaccine Controversies of the 21st Century 15 49 .
Michael Linnebacher, Claudia Maletzki, Ulrike Klier & Ernst Klar. (2011) Bacterial immunotherapy of gastrointestinal tumors. Langenbeck's Archives of Surgery 397:4, pages 557-568.
Crossref
Joseph G. Altin. 2012. Innovation in Vaccinology. Innovation in Vaccinology 135 178 .
Holger Loessner, Astrid Schwantes, Matthias Hamdorf, Uliana Komor, Sara Leschner & Siegfried Weiss. 2012. Development of Novel Vaccines. Development of Novel Vaccines 87 124 .
Agata Matejuk, Qixin Leng, Szu-Ting Chou & Archibald J Mixson. (2011) Vaccines targeting the neovasculature of tumors. Vascular Cell 3:1, pages 7.
Crossref
Fred Zepp. (2010) Principles of vaccine design—Lessons from nature. Vaccine 28, pages C14-C24.
Crossref
Almira Bartolomé, Aldara Herrero-Gil, Pilar Horcajo, José A. Orden, Ricardo de la Fuente & Gustavo Domínguez-Bernal. (2010) Salmonella enterica serovar Choleraesuis derivatives harbouring deletions in rpoS and phoP regulatory genes as vehicles for DNA vaccines. Veterinary Microbiology 141:1-2, pages 81-88.
Crossref
Valeria Guimarães, Sylvia Innocentin, Jean-Marc Chatel, François Lefèvre, Philippe Langella, Vasco Azevedo & Anderson Miyoshi. (2009) A new plasmid vector for DNA delivery using lactococci. Genetic Vaccines and Therapy 7:1.
Crossref
Luis G. Bermúdez-Humarán & Philippe Langella. (2009) Utilisation des bactéries lactiques comme vecteurs vaccinaux. Revue Francophone des Laboratoires 2009:417, pages 79-89.
Crossref
Peter Öhlschläger, Michael Quetting, Gerardo Alvarez, Matthias Dürst, Lutz Gissmann & Andreas M. Kaufmann. (2009) Enhancement of immunogenicity of a therapeutic cervical cancer DNA‐based vaccine by co‐application of sequence‐optimized genetic adjuvants. International Journal of Cancer 125:1, pages 189-198.
Crossref
David F. Gardiner, Talia Rosenberg, Jerry Zaharatos, David Franco & David D. Ho. (2009) A DNA vaccine targeting the receptor-binding domain of Clostridium difficile toxin A. Vaccine 27:27, pages 3598-3604.
Crossref
Shuanglin Xiang, Andrew C. Keates, Johannes Fruehauf, Youxin Yang, Hongnian Guo, Thu Nguyen & Chiang J. Li. 2009. siRNA and miRNA Gene Silencing. siRNA and miRNA Gene Silencing 1 14 .
Aurelio Cafaro, Iole Macchia, Maria Teresa Maggiorella, Fausto Titti & Barbara Ensoli. 2009. Pharmaceutical Biotechnology. Pharmaceutical Biotechnology 189 242 .
Joseph Lustgarten & Noweeda Mirza. 2009. Handbook on Immunosenescence. Handbook on Immunosenescence 1189 1216 .
Luis G. Bermúdez-Humarán, Silvia Innocentin, Francois Lefèvre, Jean-Marc Chatel & Philippe Langella. 2009. Prebiotics and Probiotics Science and Technology. Prebiotics and Probiotics Science and Technology 1099 1122 .
Nancy Smyth TempletonMing-Shen Dai & Georges Vassaux. 2008. Gene and Cell Therapy. Gene and Cell Therapy.
Gustavo Domínguez-Bernal, Alberto Tierrez, Almira Bartolomé, Susana Martínez-Pulgarín, Francisco J. Salguero, José Antonio Orden & Ricardo de la Fuente. (2008) Salmonella enterica serovar Choleraesuis derivatives harbouring deletions in rpoS and phoP regulatory genes are attenuated in pigs, and survive and multiply in porcine intestinal macrophages and fibroblasts, respectively. Veterinary Microbiology 130:3-4, pages 298-311.
Crossref
Gábor Nagy, Levente Emo˝dy & Tibor Pál. (2008) Strategies for the development of vaccines conferring broad-spectrum protection. International Journal of Medical Microbiology 298:5-6, pages 379-395.
Crossref
K. Dhama, Mahesh Mahendran, P. K. Gupta & A. Rai. (2008) DNA vaccines and their applications in veterinary practice: current perspectives. Veterinary Research Communications 32:5, pages 341-356.
Crossref
Jerry M. Wells & Annick Mercenier. (2008) Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nature Reviews Microbiology 6:5, pages 349-362.
Crossref
Christoph Schoen, Daniela I.M. Loeffler, Alexa Frentzen, Sabine Pilgrim, Werner Goebel & Jochen Stritzker. (2008) Listeria monocytogenes as novel carrier system for the development of live vaccines. International Journal of Medical Microbiology 298:1-2, pages 45-58.
Crossref
Jeffrey B Ulmer & John J Donnelly. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences.
Can XieJin-Sheng HeMei ZhangShao-Li XueQiang WuXiang-Dong DingWei SongYuan YuanDong-Liang LiXian-Xian ZhengYan-Yan LuZhi Shang. (2007) Oral Respiratory Syncytial Virus (RSV) DNA Vaccine Expressing RSV F Protein Delivered by Attenuated Salmonella typhimurium . Human Gene Therapy 18:8, pages 746-752.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.